Related Experiment Video
Updated: Jan 18, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
KG-MACNF: A nonlinear cross-modal fusion model for predicting drug-target interactions via multi-relational embedding
Yihan Feng1, Xixin Yang1,2, Yuanlin Guan3
1College of Computer Science and Technology, Qingdao University, Qingdao, Shandong, China.
Abstract:
Drug-target interaction (DTI) prediction is essential for the development of novel drugs and the repurposing of existing ones. However, when the features of drug and target are applied to biological networks, there is a lack of capturing the relational features of drug-target interactions. And the corresponding multimodal models mainly depend on shallow fusion strategies, which results in suboptimal performance when trying to capture complex interaction relationships. Therefore, this study proposes a novel framework named KG-MACNF. This framework utilizes knowledge graph embedding (KGE) techniques to capture multi-level relational features of entities in large-scale biological networks. Simultaneously, our innovative PoolGAT network, along with CTD descriptors, is employed to extract drug structural features and protein sequence information. Finally, by employing our innovative nonlinear-driven cross-modal attention fusion network, the framework efficiently integrates these multimodal data and generates the final DTI prediction results. Experiments on two publicly available datasets, Yamanishi_08's and BioKG, demonstrate the substantial advantages of KG-MACNF in DTI prediction. KG-MACNF demonstrates robust stability, especially under imbalanced data conditions. This study successfully overcomes the bottlenecks of prior models in utilizing modality information and feature complementarity, providing a more accurate tool for drug discovery and DTI prediction.
Related Concept Videos
Drug-Receptor Bonds
In...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Quantitative Aspects of Drug-Receptor Interaction
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

